Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease

BACKGROUND: Tolvaptan slowed the rates of total kidney volume (TKV) growth and renal function decline over a 3-year period in patients with autosomal dominant polycystic kidney disease (ADPKD) enrolled in the Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Shigeo, Muto, Satoru, Kawano, Haruna, Okada, Tadashi, Shibasaki, Yoshiyuki, Nakajima, Koji, Ibuki, Tatsuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038960/
https://www.ncbi.nlm.nih.gov/pubmed/33471240
http://dx.doi.org/10.1007/s10157-020-02009-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038960/
https://www.ncbi.nlm.nih.gov/pubmed/33471240
http://dx.doi.org/10.1007/s10157-020-02009-0

Ejemplares similares